28730 results

BCG & COVID: 1) Israeli study shows BCG vaccination during childhood had no protective effect on getting COVID-19 infection later. 2) Bladder cancer pts on BCG therapy who get COVID infection, can safely take IL-6 or IL-1 inhibitors, Just not TNF inhib. https://t.co/TlOj6b8Taf

Links:

Dr. John Cush @RheumNow  (  View Tweet)

J Merrill TNR - Lupus, TMA and COVID-19

Slides from Dr. Merrills Grand Rounds on Lupus, Vascular Complications and COVID-19

TNR Grand Rounds:IL-6 in Health & Disease

Handouts to Dr. Len Calabreses TNR Presentation

Private Practice Guys on Rheumatology During COVID-19

FDA has approved OTC availability of Voltaren Gel - now called Voltaren Arthritis Pain: a topical NSAID, 1st approved by FDA in 2007. Indicated for the pain of osteoarthritis - It has not been effective in strains, sprains, bruises, sports injuries https://t.co/Tla75Bn4H0

Links:

Dr. John Cush @RheumNow  (  View Tweet)

RheumNow Podcast - COVID Kids And Men (5.15.20)

18 minutes 39 seconds

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com

HSP071.jpg

Kids' COVID-Linked Ailment Is Not Your Typical Kawasaki Disease

RheumNow

As data continue to emerge about a multi-system inflammatory disorder in children apparently connected to COVID-19, evidence is growing that this is not your typical Kawasaki disease.

Read Article
CDC Logo

CDC on Pediatric Multi-System Inflammatory Syndrome

Jack Cush, MD

The latest hazardous spinoff to the coronavirus infection is an inflammatory, Kawasaki-like syndrome unique to children or adolescents with COVID-19. Sporadic reports from around the globe of this severe pediatric COVID syndrome have littered the news with brief mentions and little detail.

Read Article

RheumNow Podcast - COVID Kids and Men (5.15.20)

RN.podcast.resized.jpg

RheumNow Podcast - COVID Kids and Men (5.15.20)

Jack Cush, MD

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.

Read Article
Plaquenil.HCQ_.pills_.jpg (keep)

The Nine Lives of Hydroxychloroquine (Updated)

Martin J. Bergman, MD

Hydroxychloroquine is one of many medications frequently used in rheumatology practice. Its remarkable versatility is attested by its routine use in lupus, in patients with an autoimmune coagulopathy, in patients with rheumatoid arthritis, as well as in those with a low-level inflammatory arthropathy.

Read Article
injectable.jpg

High Dose Anakinra Effective in COVID-19

Jack Cush, MD

Anakinra was studied in 29 COVID(+) patients with respiratory distress and high inflammatory markers (CRP or ferritin) and compared to non-anakinra patients, those on anakinra had better survival (90% vs. 56% ;p=0·009) and greater improvements in CRP and pulmonary function (72% vs 50%) compared to controls at day 21.

Read Article
Secukinumab shown to work in 9/15 (67%) of refractory Behçet’s patients (mucosal and articular dz) by 3 mos - Retrospective study looked a complete or partial responders. #s increased to 86.7% at 6 months. Doses: either 150 or 300 mg qmonth https://t.co/a3Fp3qdbkG

Links:

Dr. John Cush @RheumNow  (  View Tweet)

Study of 140 SLE pts shows 45–50% w/ IFN-I gene expression; all correlated w/ active skin & 2/6 w/ arthritis. IFN-induced Mx1 protein correlated with IFN-I score (P<0.0001); 25% showed high PMN expression assoc w/ fever, serositis, low WBC, steroid use. https://t.co/a3Fp3qdbkG

Links:

Dr. John Cush @RheumNow  (  View Tweet)

FWIW, the Mahevas observational data and Tang et al RCT of 150 pts just published together in @bmj_latest 1. Read both as preprints, nice to see them in a respected peer reviewed journal 2. Neither support a benefit from HCQ in COVID-19 Both PDFs at https://t.co/Mbrq7bFHk0 https://t.co/rTpLnhGnkf

Links:

Mike Putman @EBRheum  (  View Tweet)
×